Aquestive Therapeutics, Inc. (AQST) quarterly income statement — complete revenue, gross profit & net income history
| Metric | Q1'26 | Q4'25 | Q3'25 | Q2'25 | Q1'25 | Q4'24 | Q3'24 | Q2'24 | Q1'24 | Q4'23 | Q3'23 | Q2'23 | Q1'23 | Q4'22 | Q3'22 | Q2'22 | Q1'22 | Q4'21 | Q3'21 | Q2'21 |
|---|
| Sales/Revenue | 14.45M | 13.02M | 12.81M | 10M | 8.72M | 11.87M | 13.54M | 20.1M | 12.05M | 13.21M | 13M | 13.24M | 11.13M | 10.68M | 11.46M | 13.27M | 12.27M | 11.08M | 13.29M | 15.35M |
| Revenue Growth % | 65.67% | 9.67% | -5.43% | -50.23% | -27.65% | -10.14% | 4.15% | 51.79% | 8.25% | 23.63% | 13.43% | -0.18% | -9.26% | -3.57% | -13.73% | -13.55% | 10.32% | 54.96% | 60.86% | -29.2% |
| Cost of Goods Sold | 3.47M | 5.84M | 4.51M | 4.56M | 3.65M | 4.52M | 4.44M | 4.53M | 4.39M | 4.68M | 4.8M | 6.62M | 4.74M | 5.3M | 4.63M | 5.24M | 4.21M | 3.37M | 4.4M | 4.47M |
| COGS % of Revenue | 24.01% | 44.84% | 35.18% | 45.6% | 41.88% | 38.09% | 32.76% | 22.52% | 36.41% | 35.43% | 36.9% | 49.97% | 42.55% | 49.66% | 40.35% | 39.52% | 34.34% | 30.38% | 33.12% | 29.1% |
| Gross Profit | 10.98M | 7.18M | 8.3M | 5.44M | 5.07M | 7.35M | 9.11M | 15.57M | 7.66M | 8.53M | 8.2M | 6.62M | 6.4M | 5.38M | 6.84M | 8.02M | 8.06M | 7.71M | 8.89M | 10.88M |
| Gross Margin % | 75.99% | 55.16% | 64.82% | 54.4% | 58.12% | 61.91% | 67.24% | 77.48% | 63.59% | 64.57% | 63.1% | 50.03% | 57.45% | 50.34% | 59.65% | 60.48% | 65.66% | 69.62% | 66.88% | 70.9% |
| Gross Profit Growth % | 116.59% | -2.29% | -8.83% | -65.05% | -33.87% | -13.84% | 10.98% | 135.1% | 19.81% | 58.58% | 19.98% | -17.44% | -20.59% | -30.28% | -23.06% | -26.25% | -3.69% | 76.84% | 68.25% | -40.01% |
| Operating Expenses | 15.18M | 36.02M | 19.78M | 16.81M | 24.43M | 20.93M | 17.39M | 15.52M | 16.62M | 12.44M | 10.58M | 10.83M | 11M | 16.09M | 15.69M | 20.79M | 17.79M | 19.38M | 16.86M | 17.4M |
| OpEx % of Revenue | 105.09% | 276.74% | 154.45% | 168.05% | 280.19% | 176.34% | 128.45% | 77.21% | 137.9% | 94.18% | 81.38% | 81.81% | 98.81% | 150.63% | 136.88% | 156.69% | 145.02% | 174.95% | 126.85% | 113.37% |
| Selling, General & Admin | 10.98M | 32.82M | 15.25M | 12.71M | 19.07M | 16.01M | 12.13M | 11.36M | 10.69M | 9.55M | 7.38M | 7.36M | 7.46M | 11.81M | 12.46M | 15.59M | 13.02M | 14.98M | 12.13M | 13.13M |
| SG&A % of Revenue | 75.99% | 252.19% | 119.08% | 127.01% | 218.72% | 134.9% | 89.54% | 56.5% | 88.68% | 72.32% | 56.8% | 55.58% | 66.96% | 110.58% | 108.69% | 117.5% | 106.12% | 135.23% | 91.28% | 85.59% |
| Research & Development | 4.2M | 3.2M | 4.53M | 4.11M | 5.36M | 4.92M | 5.27M | 4.16M | 5.93M | 2.89M | 3.2M | 3.47M | 3.55M | 4.28M | 3.23M | 5.2M | 4.77M | 4.4M | 4.73M | 4.26M |
| R&D % of Revenue | 29.1% | 24.56% | 35.37% | 41.04% | 61.48% | 41.43% | 38.91% | 20.71% | 49.22% | 21.87% | 24.58% | 26.23% | 31.86% | 40.05% | 28.2% | 39.19% | 38.9% | 39.72% | 35.57% | 27.77% |
| Other Operating Expenses | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -4.2M | -28.84M | -11.48M | -11.37M | -19.36M | -13.58M | -8.29M | 55K | -8.96M | -3.91M | -2.38M | -4.21M | -4.61M | -10.71M | -8.85M | -12.76M | -9.74M | -11.67M | -7.97M | -6.52M |
| Operating Margin % | -29.1% | -221.58% | -89.63% | -113.65% | -222.08% | -114.43% | -61.22% | 0.27% | -74.31% | -29.62% | -18.28% | -31.79% | -41.36% | -100.29% | -77.23% | -96.21% | -79.36% | -105.33% | -59.97% | -42.47% |
| Operating Income Growth % | 78.29% | -112.38% | -38.47% | -20769.09% | -116.2% | -247.2% | -248.76% | 101.31% | -94.51% | 63.49% | 73.15% | 67.02% | 52.71% | 8.19% | -11.11% | -95.83% | -14.23% | 25.42% | 42.18% | -1749.87% |
| EBITDA | -4.08M | -28.71M | -11.34M | -11.23M | -19.23M | -13.43M | -8.13M | 260K | -8.75M | -3.44M | -2.12M | -3.92M | -4.28M | -10.32M | -8.26M | -12.1M | -9.01M | -10.94M | -7.23M | -5.78M |
| EBITDA Margin % | -28.28% | -220.58% | -88.55% | -112.25% | -220.48% | -113.19% | -60.04% | 1.29% | -72.6% | -26.08% | -16.31% | -29.6% | -38.44% | -96.57% | -72.03% | -91.18% | -73.44% | -98.74% | -54.43% | -37.65% |
| EBITDA Growth % | 78.75% | -113.74% | -39.47% | -4418.46% | -119.73% | -290.01% | -283.54% | 106.63% | -104.44% | 66.62% | 74.32% | 67.59% | 52.5% | 5.69% | -14.17% | -109.36% | -15.97% | 24.77% | 44.91% | -584.65% |
| D&A (Non-Cash Add-back) | 119K | 130K | 139K | 140K | 139K | 147K | 159K | 205K | 207K | 467K | 257K | 289K | 325K | 397K | 596K | 667K | 727K | 731K | 736K | 740K |
| EBIT | -4.2M | -28.84M | -11.48M | -11.37M | -19.36M | -12.85M | -7.31M | 1.45M | -8.63M | -4.78M | -863K | -4.08M | 9.55M | -10.65M | -8.85M | -12.73M | -9.74M | -25.36M | -7.97M | -6.14M |
| Net Interest Income | -3.94M | -4.27M | -4.27M | -4.28M | -4.28M | -3.49M | -3.22M | -2.8M | -3.87M | -3.07M | 202K | -1.3M | 13.03M | -1.64M | -3.68M | -3.54M | -3.48M | -3.45M | -6.59M | -5.85M |
| Interest Income | 0 | 0 | 0 | 0 | 0 | 734K | 979K | 1.4M | 329K | 165K | 1.51M | 129K | 14.51M | 65K | 5K | 32K | 0 | 135K | 0 | 373K |
| Interest Expense | 3.94M | 4.27M | 4.27M | 4.28M | 4.28M | 4.22M | 4.2M | 4.2M | 4.2M | 3.23M | 1.31M | 1.43M | 1.49M | 1.7M | 3.69M | 3.57M | 3.48M | 3.59M | 6.59M | 6.22M |
| Other Income/Expense | -3.85M | -3.02M | -3.97M | -2.18M | -3.56M | -3.49M | -3.22M | -2.8M | -3.87M | -4.1M | 202K | -1.3M | 12.67M | -1.64M | -3.68M | -3.54M | -3.48M | -17.28M | -6.59M | -5.85M |
| Pretax Income | -8.06M | -31.86M | -15.45M | -13.55M | -22.93M | -17.07M | -11.51M | -2.75M | -12.83M | -8.01M | -2.17M | -5.51M | 8.07M | -12.35M | -12.54M | -16.3M | -13.22M | -28.95M | -14.55M | -12.37M |
| Pretax Margin % | -55.77% | -244.79% | -120.61% | -135.44% | -262.96% | -143.84% | -84.99% | -13.66% | -106.43% | -60.65% | -16.73% | -41.6% | 72.46% | -115.63% | -109.36% | -122.89% | -107.74% | -261.28% | -109.54% | -80.59% |
| Income Tax | 0 | 0 | 0 | 0 | 0 | -14K | 0 | 0 | 0 | 101K | -140K | 284K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Effective Tax Rate % | 0% | 0% | 0% | 0% | 0% | 0.08% | 0% | 0% | 0% | -1.26% | 6.44% | -5.16% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| Net Income | -8.06M | -31.86M | -15.45M | -13.55M | -22.93M | -17.05M | -11.51M | -2.75M | -12.83M | -8.11M | -2.04M | -5.79M | 8.07M | -12.35M | -12.54M | -16.3M | -13.22M | -28.95M | -14.55M | -12.37M |
| Net Margin % | -55.77% | -244.79% | -120.61% | -135.44% | -262.96% | -143.72% | -84.99% | -13.66% | -106.43% | -61.42% | -15.65% | -43.74% | 72.46% | -115.63% | -109.36% | -122.89% | -107.74% | -261.28% | -109.54% | -80.59% |
| Net Income Growth % | 64.86% | -86.81% | -34.21% | -393.55% | -78.75% | -110.27% | -465.55% | 52.61% | -259% | 34.33% | 83.77% | 64.47% | 161.03% | 57.33% | 13.87% | -31.82% | 9.9% | -42.11% | 12.06% | -429.86% |
| Net Income (Continuing) | -8.06M | -31.86M | -15.45M | -13.55M | -22.93M | -17.05M | -11.51M | -2.75M | -12.83M | -8.11M | -2.04M | -5.79M | 8.07M | -12.35M | -12.54M | -16.3M | -13.22M | -28.95M | -14.55M | -12.37M |
| Discontinued Operations | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EPS (Diluted) | -0.07 | -0.26 | -0.14 | -0.14 | -0.24 | -0.19 | -0.13 | -0.03 | -0.17 | -0.12 | -0.03 | -0.10 | 0.26 | -0.33 | -0.23 | -0.44 | -0.40 | -0.72 | -0.37 | -0.33 |
| EPS Growth % | 70.83% | -36.84% | -7.69% | -363.58% | -41.18% | -58.33% | -312.7% | 69.8% | -165.38% | 63.64% | 86.3% | 77.27% | 165% | 54.17% | 37.84% | -33.33% | 2.44% | -20% | 24.49% | -374.82% |
| EPS (Basic) | -0.07 | -0.26 | -0.14 | -0.14 | -0.24 | -0.19 | -0.13 | -0.03 | -0.17 | -0.12 | -0.03 | -0.10 | 0.35 | -0.33 | -0.23 | -0.44 | -0.40 | -0.72 | -0.37 | -0.33 |
| Diluted Shares Outstanding | 122.61M | 121.97M | 110.58M | 99.33M | 95.5M | 91.2M | 91.08M | 90.91M | 73.61M | 68.53M | 64.68M | 57.35M | 73.79M | 54.39M | 53.42M | 45.46M | 41.47M | 40.39M | 39.22M | 37.07M |
| Basic Shares Outstanding | 122.61M | 121.97M | 110.58M | 99.33M | 95.5M | 91.2M | 91.08M | 90.91M | 73.61M | 68.53M | 64.68M | 57.35M | 55.63M | 54.39M | 53.42M | 45.28M | 41.31M | 40.39M | 39.22M | 37.07M |
| Dividend Payout Ratio | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |